You are about to be taken to a third-party site. The content on this site is for informational use only. L-Nutra does not endorse any of the information, products, or services on third-party sites, and no information on third-party sites should be construed as an endorsement or recommendation of specific L-Nutra products. By clicking on the link below, you consent to be directed to external material.
Proceed CancelL-Nutra, the global leader in longevity and nutrition science, has been named a Top Vendor by Shortlister for Q4 2025 in both Corporate Weight Management and Diabetes Management Programs, solidifying its position as one of the most clinically validated, outcomes-driven nutrition companies transforming public and corporate health.
In a groundbreaking first for nutrition science, researchers have published pilot clinical trial data showing that the 5-day Fasting Mimicking Diet (FMD) was associated with increased activity of the body's natural cellular clean-up process - autophagy
Investment will launch a new joint venture in Abu Dhabi to bring nutrition technologies for healthy aging and disease remission to the MENA region.
Diabetic kidney disease is the leading cause of end-stage kidney complications in people with diabetes.
First-of-its-kind study assesses Fasting Mimicking Technology in patients with prostate cancer.
Investment will help fortify L-Nutra’s leadership in nutrition technology and advance the company’s mission of promoting healthy living and longevity.